Precision Oncology Consultation: Complete Clinical Guide, Benefits & Recovery

Clinical Overview: Understanding Precision Oncology Consultation

Precision Oncology Consultation represents a cornerstone clinical program at Spica Healthcare — Grover Hospital, Bathinda. Supervised directly by Dr. Neha Gupta (Director & Senior Medical Oncologist), this evidence-based pathway integrates sub-millimeter surgical precision, advanced intraoperative 3D navigation, ISO Class-100 Laminar Airflow surgical suites, and personalized accelerated rehabilitation to restore function, eliminate pain, and maximize long-term treatment longevity.

In South-Western Punjab and adjoining regions of Haryana and Rajasthan, patients frequently encounter delayed clinical diagnoses or generalized approaches that fail to address anatomical nuances. At Spica Healthcare, every patient undergoes rigorous digital staging, ensuring that surgical interventions or targeted medical therapies are customized to individual biomechanics and oncological requirements.

Clinical Indications: When is Precision Oncology Consultation Recommended?

• Patients with solid tumors (Lung, Colon, Breast, Prostate, Sarcoma, Ovary) seeking targeted treatment.

• Advanced or metastatic cancer patients who have progressed on standard first-line chemotherapy.

• Rare or unusual histology cancers requiring comprehensive 500+ gene NGS genomic profiling.

• Cancer of Unknown Primary (CUP) requiring molecular profiling to identify the tissue of origin.

Step-by-Step Surgical & Clinical Pathway at Grover Hospital

Step 1: Clinical History & Specimen Review

Review of clinical history, prior treatments, and tumor tissue block adequacy for genomic extraction.

Step 2: Comprehensive NGS DNA/RNA Sequencing

Comprehensive NGS sequencing analyzing actionable mutations, copy number variations, and gene fusions.

Step 3: Molecular Tumor Board Matching

Molecular Tumor Board consensus matching identified genomic alterations to targeted drugs.

Step 4: Targeted Therapy & ctDNA Tracking

Prescription of targeted therapy and serial ctDNA liquid biopsy monitoring to track tumor burden.

Director's Signature Innovation: Comprehensive Precision Oncology & Genomic Profiling

Dr. Neha Gupta leads the Precision Oncology & Cancer Genomics Unit at Spica Healthcare. Moving beyond generic chemotherapy, every tumor is analyzed using Next-Generation DNA/RNA Sequencing (NGS comprehensive 500+ gene panels, liquid biopsies, circulating tumor DNA - ctDNA, Tumor Mutational Burden - TMB, and Microsatellite Instability - MSI). By matching actionable oncogenic driver mutations to targeted oral kinase inhibitors, monoclonal antibodies, and immunotherapy, patients receive customized molecularly targeted therapy with superior tumor control and minimal toxicity.

✔ Comprehensive 500+ NGS Gene Panels: Identifies rare actionable mutations across solid tumors & sarcomas

✔ Liquid Biopsy & ctDNA Tracking: Non-invasive blood testing detecting tumor mutations and treatment response

✔ Tumor-Agnostic Therapies: FDA-approved targeted drugs for NTRK fusions, RET, BRAF, and MSI-High status

✔ Molecular Tumor Board: Expert genomic interpretation matching patients to targeted clinical therapies

Recovery Timeline & Functional Milestones

Phase 1: Genomic Panel Selection (Day 1 – 2)

Clinical oncological evaluation, review of pathology blocks, and selection of appropriate NGS genomic panel.

Phase 2: NGS Sequencing & Analysis (Day 7 – 14)

Next-Generation DNA/RNA Sequencing (NGS) and molecular tumor board interpretation by Dr. Neha Gupta.

Phase 3: Targeted Therapy Initiation (Day 14+)

Initiation of actionable targeted oral kinase inhibitor or immunotherapy regimen with regular monitoring.

Frequently Asked Clinical Questions (FAQs)

What is Precision Oncology and how does it differ from standard treatment?

Traditional oncology treats cancer based primarily on the organ where it started (e.g. breast or lung). Precision oncology analyzes the unique DNA and RNA genetic mutations driving that specific patient's tumor, allowing Dr. Neha Gupta to prescribe targeted oral tablets or biological therapies that kill the cancer with high accuracy and fewer side effects.

What is a liquid biopsy (ctDNA) and when is it used?

A liquid biopsy is a simple blood test that captures microscopic fragments of cancer DNA (circulating tumor DNA - ctDNA) shedding into the bloodstream. It allows genetic tumor profiling and monitoring of resistance mutations without needing an invasive tissue biopsy.

Is Precision Oncology covered under Ayushman Bharat?

Yes, precision oncology consultations, NGS genomic profiling reviews, targeted oral therapies, and daycare oncology care at Grover Hospital Bathinda are covered 100% cashless under PM-JAY Ayushman Bharat and 30+ private TPAs.

100% Cashless Insurance & PM-JAY Ayushman Bharat Empanelment

At Spica Healthcare — Grover Hospital Bathinda, Precision Oncology Consultation is fully covered under the Government of India's PM-JAY Ayushman Bharat scheme and over 30+ leading private insurance TPAs. Our on-campus insurance coordinator handles all pre-authorization documentation directly with your insurance company, eliminating financial delays. Families can also share digital DICOM CDs and biopsy reports via WhatsApp (+91 95013 73003) for an urgent surgical review.